This article discusses the evidence related to the common practice of using Betaine HCl to increase stomach acid (and improve digestion) during a meal.
In this radio interview, Dr. Thomas Guilliams discusses the data on fish oil, how to choose a fish oil product and some of the key issues surrounding fish oil supplements. [click title to download and listen to the February 6 podcast].
In this article, Dr. Thomas Guilliams reviews the recent editorial on multivitamins in the Annals of Internal Medicine. Examines and breaks down bias in the TACT, PHS2 and a systematic review of studies on vitamins for prevention of CVD and cancer.
In this radio interview, Dr. Thomas Guilliams gives a detailed critique of the recent Annals of Medicine studies on multivitamins.
Dr. Thomas Guilliams is interviewed about the Seven Pillars of good health, as discussed in The Original Prescription (video included).
Roni Enten gives tips about the importance of diet and nutrition one of the seven spheres of Lifestyle Synergy discussed in The Original Prescription.
In this radio interview, Dr. Guilliams is interviewed by Dr. Ronald Hoffman about The Original Prescription and the powerful potential of lifestyle medicine.
Discusses well-researched botanicals and nutraceutical immunomodulators, with a focus on clinical trials and mechanisms from in vitro and animal research. Includes sections on key nutrients such as zinc, vitamin A and vitamin C, as well as Echinacea, mushroom extracts, astragalus, andrographis, and probiotics.
The Use of Fish Oil Supplements in Clinical Practice: A Review (JANA Vol. 8, No.1 – reprint 2005)
Focuses on the clinical data on fish consumption, fish oil supplements and their fatty acids, with an emphasis on cardiovascular health. Also includes a discussion of non-cardiovascular uses, including mood disorders, brain development and ocular health.
Homocysteine – A Risk Factor for Vascular Diseases: Guidelines for the Clinical Practice (JANA Vol 7, No.1 – Winter 2004)
Reviews the history of homocysteine research and related clinical intervention trials, and the rationale for homocysteine as a causative agent rather than just a marker for vascular diseases. Includes a review of homocysteine metabolism, risk factor assessment, related diseases and key supplements for reducing homocysteine levels.